Beijing Airdoc Technology Co., Ltd. (2251.HK) Stock Competitors & Peer Comparison

2251.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2251.HK stands at 1B. In comparison, 2359.HK has a market cap of 440.3B. Regarding current trading prices, 2251.HK is priced at HK$10.30, while 2359.HK trades at HK$158.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2251.HK currently has a P/E ratio of -5.60, whereas 2359.HK's P/E ratio is 19.49. In terms of profitability, 2251.HK's ROE is -0.02%, compared to 2359.HK's ROE of +0.27%. Regarding short-term risk, 2251.HK is less volatile compared to 2359.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2251.HK.Check 2359.HK's competition here

2251.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2251.HK stands at 1B. In comparison, 2268.HK has a market cap of 67.4B. Regarding current trading prices, 2251.HK is priced at HK$10.30, while 2268.HK trades at HK$56.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2251.HK currently has a P/E ratio of -5.60, whereas 2268.HK's P/E ratio is 42.71. In terms of profitability, 2251.HK's ROE is -0.02%, compared to 2268.HK's ROE of +0.16%. Regarding short-term risk, 2251.HK is less volatile compared to 2268.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2251.HK.Check 2268.HK's competition here

2251.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2251.HK stands at 1B. In comparison, 6127.HK has a market cap of 32.5B. Regarding current trading prices, 2251.HK is priced at HK$10.30, while 6127.HK trades at HK$25.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2251.HK currently has a P/E ratio of -5.60, whereas 6127.HK's P/E ratio is 31.32. In terms of profitability, 2251.HK's ROE is -0.02%, compared to 6127.HK's ROE of +0.06%. Regarding short-term risk, 2251.HK is less volatile compared to 6127.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2251.HK.Check 6127.HK's competition here

2251.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2251.HK stands at 1B. In comparison, 9860.HK has a market cap of 2.8B. Regarding current trading prices, 2251.HK is priced at HK$10.30, while 9860.HK trades at HK$4.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2251.HK currently has a P/E ratio of -5.60, whereas 9860.HK's P/E ratio is 89.44. In terms of profitability, 2251.HK's ROE is -0.02%, compared to 9860.HK's ROE of N/A. Regarding short-term risk, 2251.HK and 9860.HK have similar daily volatility (0.00).Check 9860.HK's competition here

2251.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2251.HK stands at 1B. In comparison, 8037.HK has a market cap of 634.2M. Regarding current trading prices, 2251.HK is priced at HK$10.30, while 8037.HK trades at HK$0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2251.HK currently has a P/E ratio of -5.60, whereas 8037.HK's P/E ratio is -3.18. In terms of profitability, 2251.HK's ROE is -0.02%, compared to 8037.HK's ROE of -0.31%. Regarding short-term risk, 2251.HK is less volatile compared to 8037.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2251.HK.Check 8037.HK's competition here

2251.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2251.HK stands at 1B. In comparison, 2325.HK has a market cap of 368.8M. Regarding current trading prices, 2251.HK is priced at HK$10.30, while 2325.HK trades at HK$0.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2251.HK currently has a P/E ratio of -5.60, whereas 2325.HK's P/E ratio is -1.36. In terms of profitability, 2251.HK's ROE is -0.02%, compared to 2325.HK's ROE of +0.00%. Regarding short-term risk, 2251.HK is less volatile compared to 2325.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2251.HK.Check 2325.HK's competition here

2251.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2251.HK stands at 1B. In comparison, 8247.HK has a market cap of 192.2M. Regarding current trading prices, 2251.HK is priced at HK$10.30, while 8247.HK trades at HK$3.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2251.HK currently has a P/E ratio of -5.60, whereas 8247.HK's P/E ratio is -7.29. In terms of profitability, 2251.HK's ROE is -0.02%, compared to 8247.HK's ROE of N/A. Regarding short-term risk, 2251.HK and 8247.HK have similar daily volatility (0.00).Check 8247.HK's competition here

2251.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2251.HK stands at 1B. In comparison, 0928.HK has a market cap of 120.3M. Regarding current trading prices, 2251.HK is priced at HK$10.30, while 0928.HK trades at HK$0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2251.HK currently has a P/E ratio of -5.60, whereas 0928.HK's P/E ratio is 8.39. In terms of profitability, 2251.HK's ROE is -0.02%, compared to 0928.HK's ROE of +0.01%. Regarding short-term risk, 2251.HK and 0928.HK have similar daily volatility (0.00).Check 0928.HK's competition here